Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder in Patients With a Characterized Depressive Episode in Primary Care

NCT07031817 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT07031817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07031817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder in Patients With a Characterized Depressive Episode in Primary Care
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Recruiting
Start date
September 30, 2025
Completion date
July 1, 2028
Enrollment
623 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder (bd), major depression, major depressive episode (mde), primary care